In particular it has been shown that p27 expression is regulated by a proteasome-dependent degradation [4] and that this mechanism plays a pivotal role in the regulation of p27 expression in several type of human tumors, as first demonstrated in breast and colon cancer [5]–[6]. This evidence concerns the gene CDKN1B and malignant colon neoplasm.